| PERIOD ENDING | 30-Apr-09 |
| Total Revenue |
-
|
| Cost of Revenue | 8 |
|
| Gross Profit | (8) |
|
| Operating Expenses |
| Research Development |
-
|
| Selling General and Administrative |
-
|
| Non Recurring |
-
|
| Others |
-
|
| |
| Total Operating Expenses |
-
|
|
|
| Operating Income or Loss | (8) |
|
| Income from Continuing Operations |
| Total Other Income/Expenses Net |
-
|
| Earnings Before Interest And Taxes | (8) |
| Interest Expense |
-
|
| Income Before Tax | (8) |
| Income Tax Expense |
-
|
| Minority Interest |
-
|
| |
| Net Income From Continuing Ops | (8) |
|
| Non-recurring Events |
| Discontinued Operations |
-
|
| Extraordinary Items |
-
|
| Effect Of Accounting Changes |
-
|
| Other Items |
-
|
|
|
| Net Income | (8) |
| Preferred Stock And Other Adjustments |
-
|
|
| Net Income Applicable To Common Shares | ($8) |
0.09% Nasdaq 
0.15%
Income Statement
